Showing 311-320 of 4523 results for "".
Off-label Uses for Biologics
https://practicaldermatology.com/topics/psoriasis/off-label-uses-for-biologics/18964/Derm Insider Bonus Content: Host Neal Bhatia speaks with guests Alice Gottlieb, MD, Harold Farber, MD, and James Ulery, MD about various potential off-label uses for current and investigational systemic psoriasis therapies.Various Skin Cancer Therapies Covered at Maui Derm
https://practicaldermatology.com/conferences/maui-derm-hawaii-2025/various-skin-cancer-therapies-covered-at-maui-derm/32915/With a theme of understanding the various options available for treatment of skin cancers and selecting the correct ones for each case, George Martin, MD, Ted Rosen, MD, and Emily Ruiz, MD, MPH, presented “Cutaneous Oncology Update 2025” at the Maui Derm Hawaii 2025 meeting in Maui, Hawaii.Canadian Perspective: Drs. Bhatia, Sapijaszko, and Kaufmann
https://practicaldermatology.com/conferences/maui-derm-hawaii-2025/canadian-perspective-drs-bhatia-sapijaszko-and-kaufmann/32695/Neal Bhatia, MD, speaks with Canadian Dermatology Association vice president Mariusz Sapijaszko, MD, FAACS, and former American Academy of Dermatology president Mark Kaufmann, MD, about different perspectives on advocacy in dermatology, including the use of patient stories.Defining the Physician-Patient Relationship
https://practicaldermatology.com/topics/practice-management/defining-the-physician-patient-relationship/18928/In this edition of Derm Insider, Allan Wirtzer, MD and Cliff Lober, MD, JD talk to host Neal Bhatia, MD about the importance of defining the physician-patient relationship, determining when the relationship is established, and understanding the legal implications that come with that fiduciary or heiScientifically Speaking: Correcting and Avoiding Complications in Dark Skin Tones, Part 2 of 2
https://practicaldermatology.com/topics/skin-cancer-photoprotection/scientifically-speaking-correcting-and-avoiding-complications-in-dark-skin-tones-part-2-of-2/19898/Advancements in energy-based devices mean that these tools can be used across a range of skin tones. But complications can and do still occur. In part two of a discussion on EBDs used in darker skin types, host Joel L. Cohen, MD reviews cases with Michelle Henry, MD, Omar Ibrahimi, MD, PhD, and JennJejunal Trichobezoar in a 3-year-old Boy; Practice Path MD Pro Tip: Architects
https://practicaldermatology.com/youngmd-connect/resident-resource-center/jejunal-trichobezoar-in-a-3-year-old-boy-practice-path-md-pro-tip-architects/20697/Journal Club: Tapinarof Cream in Pediatric Patients
https://practicaldermatology.com/programs/Practical-Dermatology-Atopic-Dermatitis-Journal-Club/journal-club-tapinarof-cream-in-pediatric-patients/32399/Practical Dermatology Editorial Board member Peter Lio, MD, speaks with Mona Shahriari, MD, about the Journal of Dermatology article "A phase 2, randomized, double-blind, vehicle-controlled trial of tapinarof cream in Japanese pediatric patients with atopic dermatitis," and the general importance ofRevealed: The Two Hottest New Skin Cancer Ingredients
https://practicaldermatology.com/conferences/scale-2023/revealed-the-two-hottest-new-skin-cancer-ingredients/20202/Todd Schlesinger, MD, discusses the growing role of exosomes and cannabidiol (CBD) in dermatology.What’s In My Black Bag?
https://practicaldermatology.com/topics/practice-management/whats-in-my-black-bag/23651/CSF faculty member Jeanine Downie, MD dishes on her favorite products.Acne & Rosacea: 2020 and Beyond
https://practicaldermatology.com/topics/acne-rosacea/acne-rosacea-2020-and-beyond/19734/Guy Webster, MD, PhD reviews developments in acne and rosacea.